In 1796, Edward Jenner noticed that milkmaids who caught cowpox never seemed to get smallpox. He didn't know about B cells, T cells, or memory lymphocytes. He just noticed the pattern — and acted on it. The mechanism he accidentally discovered is the same one behind every vaccine ever made.
Use the PDF for classwork, homework or revision. It includes key ideas, activities, questions, an extend task and success-criteria proof.
Edward Jenner's 1796 experiment: he took material from a cowpox pustule on a milkmaid's hand and scratched it into the arm of James Phipps, an 8-year-old boy. The boy developed mild cowpox symptoms, then recovered. Six weeks later, Jenner exposed the boy to smallpox — and nothing happened. The boy was protected.
Before reading: at the molecular and cellular level, why do you think the cowpox exposure protected James Phipps against smallpox? What was happening in his immune system during those six weeks?
Come back to this at the end of the lesson.
Core Content
Jenner observed that dairy workers who contracted cowpox (a mild disease caused by vaccinia virus, related to but distinct from smallpox) appeared to be protected from smallpox — then one of the deadliest diseases in Europe. He tested this systematically by inoculating James Phipps with cowpox material, then challenging him with smallpox six weeks later. Phipps showed no symptoms. Jenner called his procedure "vaccination" from vacca (Latin: cow). He had no knowledge of B cells, T cells, or immunological memory — he simply demonstrated that prior exposure to a related mild pathogen conferred protection against a lethal one. His work preceded the germ theory of disease by nearly a century.
What Jenner discovered — without understanding the mechanism — was that the immune system forms a memory after first exposure to an antigen. Cowpox and smallpox viruses share enough antigenic similarity that the memory B and T cells formed during cowpox infection also recognise smallpox antigens. When smallpox arrived, Phipps mounted an immediate secondary response — eliminating the virus before it caused disease.
The primary immune response is the body's first encounter with a specific antigen. The secondary response is every subsequent encounter with the same antigen. The difference between them — in speed, magnitude, and antibody quality — is entirely explained by immunological memory.
Vaccination triggers a primary response and memory formation — if the real pathogen arrives later, the secondary response clears it before symptoms develop
| Feature | Primary Response | Secondary Response |
|---|---|---|
| Trigger | First exposure (infection or vaccination) | Re-exposure to same antigen |
| Lag period | 7–14 days to peak | 1–3 days to peak |
| Antibody peak | Relatively low | 10–100× higher |
| Antibody class | IgM first, then IgG | Mainly high-affinity IgG |
| Duration | Weeks | Months to years |
| Memory formed? | Yes — memory B and T cells produced | Yes — memory pool reinforced |
| Outcome | Person often becomes ill before response peaks | Usually cleared before symptoms develop |
A vaccine introduces antigens (or instructions to make antigens) into the body in a form that cannot cause the full disease. The immune system mounts a primary response — producing memory B and T cells — without the person suffering significant illness. When the real pathogen arrives later, the secondary response is already primed.
All vaccine types work by the same principle: trigger a primary response and memory formation without causing the full disease
Memory B and T cell populations decline over time if not reinforced by re-exposure. A booster dose acts as a second exposure — triggering a secondary response that elevates antibody levels and expands the memory cell population. Vaccines requiring boosters include tetanus (every 10 years), influenza (annually, because the virus mutates), and some childhood vaccines like diphtheria-tetanus-pertussis (DTP) which are given in a series to build adequate memory.
When enough individuals in a population are immune (through vaccination or prior infection), transmission chains break — even unvaccinated individuals are protected because the pathogen cannot find enough susceptible hosts to spread effectively. The threshold varies by pathogen: measles requires ~95% immunity; polio ~80–85%; COVID-19 varied with variant. Herd immunity is critical for protecting those who cannot be vaccinated — newborns, immunocompromised individuals, and those with vaccine contraindications.
Edward Jenner's 1796 experiment was contested, ridiculed, and eventually vindicated on a global scale. The mechanism he accidentally exploited — cross-reactive immunological memory between cowpox and smallpox antigens — worked because the two viruses share enough antigenic similarity that memory B and T cells raised against cowpox antigens also recognise and respond rapidly to smallpox antigens.
You will apply memory cell and vaccination concepts in Activity 01 and Short Answer Q3.
Misconception: Vaccination gives you the disease in a mild form — you are actually being infected.
Most vaccines do not contain live, disease-causing pathogens. Inactivated vaccines use killed organisms; subunit vaccines use isolated proteins; mRNA vaccines provide instructions to make a single antigen. Only live-attenuated vaccines contain living pathogens, but these are so weakened that they cannot cause the full disease in immunocompetent individuals. In all cases, the goal is antigen exposure without significant disease — triggering the primary response and memory formation.
Misconception: If you have antibodies against a pathogen, you are immune — the level doesn't matter.
Immunity is not binary. Antibody levels must be above a protective threshold to prevent infection. Levels that were once protective may decline below the threshold over time — which is why boosters are necessary for some vaccines. Additionally, the speed of the secondary response matters: if a pathogen replicates faster than memory cells can respond, infection can still establish even with some memory present. A very small residual antibody level with high memory cell numbers is often more protective than a moderate antibody level with no memory.
Misconception: Natural infection always gives better immunity than vaccination.
This varies considerably by pathogen. For some diseases, natural infection does produce broader and more durable immunity — but at the cost of the risks of the disease itself. For others, vaccination produces equal or superior immunity: the HPV vaccine produces higher antibody levels than natural infection; the Hep B vaccine produces more consistent immunity than infection. The critical difference is that vaccines provide immunity without the risks of the disease — including serious complications, transmission to vulnerable others, and death.
Primary vs Secondary Immune Response
Activities
Context: The measles-mumps-rubella (MMR) vaccine is a live-attenuated vaccine given in two doses in Australia: the first at 12 months, the second at 18 months. The measles vaccine produces lifelong immunity in approximately 97% of recipients who receive both doses. A single dose produces immunity in ~93% of recipients.
Antibody data after MMR vaccination:
Write your responses here or in your book.
Not all immunity is generated by an individual's own immune response. Passive immunity involves receiving pre-formed antibodies from another source — bypassing the primary response entirely.
Examples of passive immunity:
Write your responses here or in your book.
You were asked why the cowpox exposure protected James Phipps against smallpox, and what was happening in his immune system during the six weeks between exposures.
The mechanism: during those six weeks, Phipps's immune system was mounting a primary response to cowpox antigens — clonal selection of matching B cells, clonal expansion, plasma cell production (clearing the mild cowpox infection), and formation of memory B and T cells. The memory cells then persisted. When smallpox arrived, the cross-reactive memory cells recognised the shared antigens and mounted an immediate secondary response — before the virus could establish a significant infection.
If you predicted that "his immune system remembered the cowpox virus" — essentially correct, though the memory is stored in specific long-lived lymphocytes, not as a general state of alertness. If you predicted "antibodies were already in the blood" — partially right, but declining. The key is that even as antibody levels decline, the memory cell population persists and can rapidly regenerate antibodies on demand. If you did not predict the cross-reactivity between cowpox and smallpox — that is the crucial piece of biology Jenner observed empirically without understanding the mechanism.
5 random questions from a replayable lesson bank — feedback shown immediately
1. Describe what happens at the cellular level during the primary immune response to a vaccine. In your answer, identify the cells involved and explain what two populations are produced at the end of the response. (3 marks)
1 mark: antigen presented → clonal selection of matching B cell → T helper activation | 1 mark: clonal expansion → plasma cells (antibody production) | 1 mark: memory B and T cells formed — persist long-term
2. Compare the primary and secondary immune responses, referring to lag period, antibody level, antibody class, and outcome for the individual. (3 marks)
1 mark: lag period comparison (7–14 days vs 1–3 days) | 1 mark: antibody level and class (low IgM then IgG vs high mainly IgG) | 1 mark: outcome (may become ill vs cleared before symptoms in most cases)
3. Explain how Edward Jenner's cowpox vaccination produced protection against smallpox in James Phipps. In your answer, refer to clonal selection, memory B cells, and the secondary immune response. Also explain why this approach eventually led to the global eradication of smallpox. (4 marks)
1 mark: cowpox exposure → primary response → clonal selection of B cells matching cowpox antigens | 1 mark: memory B and T cells formed against cowpox antigens — which also recognise smallpox due to antigenic similarity | 1 mark: smallpox challenge → secondary response — rapid high-level antibody production cleared virus before disease | 1 mark: global vaccination created sufficient herd immunity → transmission chains broken → eradication
Answers
SA1: When a vaccine antigen enters the body, dendritic cells engulf it and present antigen fragments on MHC class II molecules, migrating to lymph nodes. In the lymph node, the antigen is encountered by the pool of naive B cells — each with a unique B cell receptor (BCR). Through clonal selection, the specific B cell whose BCR matches the vaccine antigen binds it and receives a co-stimulatory signal from a T helper cell that has independently recognised the same antigen. This activated B cell undergoes clonal expansion — dividing rapidly to produce a large clone of identical cells. These differentiate into two distinct populations: plasma cells, which are short-lived antibody factories that secrete specific antibodies (initially IgM, then class-switched to IgG) over the following weeks; and memory B cells, which are long-lived and persist in lymph nodes and bone marrow for years to decades. Memory T cells (both helper and cytotoxic) are also formed simultaneously. It is these memory cells — not the antibodies — that provide the lasting foundation for protective immunity.
SA2: The primary immune response has a lag period of 7–14 days from antigen exposure to peak antibody production — this delay reflects the time needed for naive B cell clonal selection, T helper activation, clonal expansion, and plasma cell differentiation. The antibodies produced are initially IgM (the first class secreted, lower affinity) followed by class switching to IgG. The peak antibody level is relatively low — sufficient to eventually clear the infection but typically after the person has already become symptomatic. The secondary immune response has a lag period of only 1–3 days — memory B cells are already clonally selected and present in large numbers, so they can immediately differentiate into plasma cells without the slow selection process. The antibodies produced are predominantly high-affinity IgG from the start. The peak antibody level is 10–100 times higher than the primary peak and is maintained for a longer duration. The outcome differs significantly: during the primary response, the person typically becomes ill before the response peaks; during the secondary response, the infection is usually cleared before antibody levels reach a threshold that causes significant symptoms — the person is effectively protected.
SA3: When James Phipps was inoculated with cowpox material, his immune system mounted a primary response against cowpox antigens. Dendritic cells processed cowpox viral antigens and presented them in lymph nodes. The specific B cell clones whose BCRs matched cowpox antigenic epitopes underwent clonal selection, receiving T helper co-stimulation, and expanded into plasma cells (producing anti-cowpox antibodies that cleared the mild cowpox infection) and memory B and T cells. These memory cells persisted in Phipps's lymphoid tissue after the infection resolved. Six weeks later, when Jenner exposed Phipps to smallpox, the key was antigenic similarity: cowpox virus (vaccinia) and smallpox virus (variola) share multiple surface antigens — enough that the memory B and T cells raised against cowpox antigens also recognised smallpox antigens as familiar. Rather than mounting a slow primary response against a new antigen, Phipps's immune system mounted a secondary response — memory B cells were rapidly activated within hours, differentiating into plasma cells that flooded the bloodstream with high-affinity IgG antibodies within 1–3 days. The smallpox virus was neutralised and cleared before it could replicate to disease-causing levels. Phipps showed no smallpox symptoms. When this vaccination approach was scaled globally — using vaccinia virus vaccine in a worldwide WHO campaign from 1967 — it progressively reduced the pool of susceptible individuals in every country. As vaccination coverage increased, transmission chains broke; the virus could not find enough susceptible hosts to sustain itself. The last natural case occurred in 1977; smallpox was declared eradicated in 1980. It remains the only human infectious disease eradicated in history — a direct result of the secondary immune response mechanism Jenner observed but could not explain.
Defend your ship by blasting the correct answers for Primary and Secondary Immune Response. Scores count toward the Asteroid Blaster leaderboard.
Play Asteroid Blaster →